Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Black Diamond Therapeutics, Inc.

Clinical trials sponsored by Black Diamond Therapeutics, Inc., explained in plain language.

Black Diamond Therapeutics, Inc. BDTX NASDAQ

Clinical-stage oncology company developing precision cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New hope for glioblastoma? drug combo trial targets aggressive brain tumors

Disease control Recruiting now

This Phase 2 trial tests whether adding the experimental drug silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of newly diagnosed glioblastoma live longer without their cancer worsening. The study includes 162 participants whose tumors have c…

Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC